Tracheobronchopulmonary Carcinoid Tumors: Analysis of 40 Patients

Tumeurs carcinoïdes bronchopulmonaires : une série tunisienne de 115 cas opérés

“…La symptomatologie est d'autant plus riche que la tumeur est proximale. Les patients symptomatiques peuvent se présenter avec des hémoptysies, une toux chronique, des douleurs thoraciques, une dyspnée, un wheezing unilatéral ou des infections récurrentes [11,12]. La symptomatologie dépend étroitement du siège de la tumeur.…”

Defining the Role of Adjuvant Chemotherapy After Lobectomy for Typical Bronchopulmonary Carcinoid Tumors

“…A subanalysis of this trial by Fazio and colleagues [6] evaluated only the patients with bronchopulmonary carcinoids and confirmed a 2.4-fold improvement in progression-free survival. Among patients with atypical carcinoids and positive lymph nodes, current guidelines advocate adjuvant systemic chemotherapy, although these recommendations are based on limited data mostly extrapolated from the aforementioned studies regarding locally advanced or metastatic disease [3,5,6,[9][10][11][12]. For patients with typical carcinoids and positive lymph nodes, almost no data exist on the use of adjuvant chemotherapy, and guidelines currently recommend observation alone for these patients.…”

Endobronchial Treatment for Bronchial Carcinoid: Patient Selection and Predictors of Outcome

“…Previous studies showed that parenchyma-sparing therapy (e.g., bronchoscopic resection, bronchial sleeve resections), without lymph node dissection, did not influence survival in patients with TC and AC [4, 5, 8, 18-20]. In contrast, other studies showed nodal status to be a very important prognostic factor, particularly in AC [11, 13-15, 21-26]. With this in mind, preoperative staging of TC and AC, with specific attention to lymph node status, is very important, especially when treating patients with minimal invasive techniques like EBT, as lymph nodes are not sampled during this technique.…”